Siemens Healthineers, with over 125 years of experience, is a leading global medical technology company dedicated to pioneering breakthroughs in healthcare. Their comprehensive portfolio encompasses medical imaging, laboratory diagnostics, point-of-care testing, and advanced therapies, including image-guided therapy and cancer care solutions. Emphasizing innovation and sustainability, Siemens Healthineers integrates artificial intelligence and digital health solutions to enhance patient outcomes and optimize clinical workflows. With a presence in over 70 countries, they serve healthcare providers worldwide, addressing challenges across various medical disciplines.
The strategic partnership integrates AI-enabled MRI protocols and digital twin technology to enhance care for neurodegenerative diseases, prostate cancer, and metastatic liver tumors.
Rising demand for precision in image-guided therapy drives adoption of AI-based live denoising, delivering clearer images at the same dose. Optiq AI debuts across three new platforms.
The 100 cm flared bore enhances access and ergonomics, using advanced imaging and radiation-free guidance for confident planning and precise targeting during minimally invasive procedures.
New radiology suite spans the entire workflow from scheduling to reporting, using custom AI for clinical insights and ActExcell simulation to optimize hospital operations.
The benchtop analyzer delivers clinical-quality results with up to 225 tests per hour, 69% higher productivity, over 65 assays, and automated specimen validity checks for unmatched reliability.